Yongqiang Lin1,
Xiang Chen2 ,
Zaizai Lin3,
Weiwei Yan4
For correspondence:- Xiang Chen Email: x_chen0427@163.com Tel:+8657788002037
Accepted: 1 September 2022 Published: 30 September 2022
Citation: Lin Y, Chen X, Lin Z, Yan W. Dexmedetomidine alleviates high glucose-induced podocyte damage by inhibiting EDA2R. Trop J Pharm Res 2022; 21(9):1885-1891 doi: 10.4314/tjpr.v21i9.11
© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Archives
News Updates